Laxness's realignment bolsters Q2 ebitda, as sales decline

August 10, 2016

Specialty chemicals manufacturer Laxness has reported net income down 13.8 per cent to E75 million in the second quarter of 2016, on sales that decreased by 7.7 per cent to E1.94 billion.

Read more...

Previous Article
Laxness's realignment bolsters operational results, as sales decline
Laxness's realignment bolsters operational results, as sales decline

Specialty chemicals manufacturer Laxness has reported net income down 13.8 per cent to E75 million in the s...

Next Article
Lanxess's realignment bolsters Q2 ebitda, as sales decline
Lanxess's realignment bolsters Q2 ebitda, as sales decline

Specialty chemicals manufacturer Lanxess has reported net income down 13.8 per cent to E75 million in the s...